JP2021516271A5 - - Google Patents
Info
- Publication number
- JP2021516271A5 JP2021516271A5 JP2020544672A JP2020544672A JP2021516271A5 JP 2021516271 A5 JP2021516271 A5 JP 2021516271A5 JP 2020544672 A JP2020544672 A JP 2020544672A JP 2020544672 A JP2020544672 A JP 2020544672A JP 2021516271 A5 JP2021516271 A5 JP 2021516271A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- alginate
- compound
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024010323A JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637803P | 2018-03-02 | 2018-03-02 | |
| US62/637,803 | 2018-03-02 | ||
| US201862652883P | 2018-04-04 | 2018-04-04 | |
| US62/652,883 | 2018-04-04 | ||
| PCT/US2019/020405 WO2019169333A1 (en) | 2018-03-02 | 2019-03-01 | Afibrotic compounds, devices, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024010323A Division JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516271A JP2021516271A (ja) | 2021-07-01 |
| JP2021516271A5 true JP2021516271A5 (enExample) | 2022-03-10 |
Family
ID=65812415
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544672A Pending JP2021516271A (ja) | 2018-03-02 | 2019-03-01 | 抗線維化化合物、デバイス、及びその使用 |
| JP2024010323A Pending JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024010323A Pending JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12605486B2 (enExample) |
| EP (1) | EP3759101A1 (enExample) |
| JP (2) | JP2021516271A (enExample) |
| KR (1) | KR20210004969A (enExample) |
| CN (1) | CN112105612A (enExample) |
| AU (2) | AU2019226587A1 (enExample) |
| CA (1) | CA3092121A1 (enExample) |
| IL (1) | IL276753B2 (enExample) |
| TW (1) | TW201938592A (enExample) |
| WO (1) | WO2019169333A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY38389A (es) * | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | Dispositivos implantables para terapia celular y métodos relacionados |
| WO2021062273A1 (en) * | 2019-09-27 | 2021-04-01 | Sigilon Therapeutics, Inc. | Methods of evaluating small molecule-modified polymers in compositions |
| EP4061942A4 (en) | 2019-11-22 | 2023-12-20 | Sigilon Therapeutics, Inc. | MONOCLONAL CELL LINES EXPRESSING AN EXOGENEOUS SUBSTANCE AND THEIR USES |
| CN117940504A (zh) * | 2021-06-14 | 2024-04-26 | 威廉马什莱斯大学 | 含有三唑的聚合物及其使用方法 |
| EP4531879A1 (en) | 2022-05-25 | 2025-04-09 | Flagship Pioneering Innovations VI, LLC | Compositions of secretory and/or catalytic cells and methods using the same |
| JP2025520113A (ja) | 2022-06-03 | 2025-07-01 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | 組成物及び方法 |
| US20260008873A1 (en) | 2022-07-01 | 2026-01-08 | Matthew Buchanan | Covalently photocrosslinked polysaccharides and methods of use thereof |
| CN116023525B (zh) * | 2023-02-13 | 2024-03-15 | 湖北工程学院 | 一种2-位(1,4-二取代-1,2,3-三唑)修饰的壳聚糖衍生物及其制备方法和应用 |
| EP4680196A1 (en) | 2023-03-14 | 2026-01-21 | Sigilon Therapeutics, Inc. | Hydrogel capsules comprising covalently photocrosslinked polysaccharides and islet cells |
| WO2026026917A1 (zh) * | 2024-07-31 | 2026-02-05 | 北京拓界生物医药科技有限公司 | 一种修饰的聚合物及其用途 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| WO1999043271A1 (en) | 1998-02-27 | 1999-09-02 | Bioelastics Research, Ltd. | Injectable implants for tissue augmentation and restoration |
| US20090042283A1 (en) | 1998-09-29 | 2009-02-12 | Shire Human Genetic Therapies, Inc., A Delaware Corporation | Optimized messenger rna |
| US6361771B1 (en) | 1999-04-06 | 2002-03-26 | Neurotech S.A. | ARPE-19 as a platform cell line for encapsulated cell-based delivery |
| JP2004532234A (ja) | 2001-04-27 | 2004-10-21 | バーテックス ファーマシューティカルズ インコーポレイテッド | トリアゾール由来キナーゼインヒビターおよびその使用 |
| WO2004064971A2 (en) | 2003-01-23 | 2004-08-05 | Inotech Ag | Process for preparing microcapsules having an improved mechanical resistance |
| PE20080906A1 (es) | 2006-08-17 | 2008-07-05 | Kemia Inc | Derivados heteroarilo como inhibidores de citocina |
| US20080242694A1 (en) | 2006-09-18 | 2008-10-02 | D Sidocky Neil R | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| WO2010005533A2 (en) | 2008-06-30 | 2010-01-14 | The Johns Hopkins University | Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| CA2750027C (en) | 2009-01-23 | 2020-11-10 | Nsgene A/S | Improved cell lines and their use in encapsulated cell biodelivery |
| JP5725475B2 (ja) | 2010-01-21 | 2015-05-27 | 公立大学法人名古屋市立大学 | ヒドロキサム酸誘導体及びそれを用いたｈｄａｃ８阻害剤 |
| WO2012112982A2 (en) | 2011-02-18 | 2012-08-23 | Massachusetts Institute Of Technology | Hydrogel encapsulated cells and anti-inflammatory drugs |
| CA2837558C (en) | 2011-06-02 | 2018-11-20 | Massachusetts Institute Of Technology | Modified alginates for cell encapsulation and cell therapy |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| US10172791B2 (en) | 2013-03-14 | 2019-01-08 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
| EA029052B1 (ru) | 2013-03-14 | 2018-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с |
| US9555007B2 (en) | 2013-03-14 | 2017-01-31 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
| GB201304973D0 (en) | 2013-03-19 | 2013-05-01 | Profactor Pharma Ltd | Recombinant protein |
| ITTO20130356A1 (it) | 2013-05-03 | 2014-11-04 | Uni Degli Studi Del Piemonte Orientale Ame | Inibitori di nicotinamide fosforibosil transferasi, relative composizioni, prodotti ed usi |
| EP2994483A4 (en) | 2013-05-06 | 2017-02-08 | Cell Machines, Inc. | Methods and compositions related to large scale production of proteins |
| EP3043836B1 (en) | 2013-09-11 | 2023-05-10 | Neurotech USA, Inc. | Encapsulated cell therapy cartridge |
| PT3628334T (pt) | 2014-03-21 | 2023-09-26 | Genzyme Corp | Terapia genética para retinopatia pigmentar |
| CN104072478B (zh) | 2014-05-22 | 2016-06-01 | 大连理工大学 | 一类萘环4位含1,2,3-三唑的萘酰亚胺衍生物的合成及其应用 |
| US11008561B2 (en) | 2014-06-30 | 2021-05-18 | Bioverativ Therapeutics Inc. | Optimized factor IX gene |
| ES3036749T3 (en) | 2014-08-01 | 2025-09-23 | Massachusetts Inst Technology | Modified alginates for anti-fibrotic materials and applications |
| JP2018521717A (ja) | 2015-05-17 | 2018-08-09 | マサチューセッツ インスティテュート オブ テクノロジー | 細胞および細胞凝集体を封入するための多層ヒドロゲルカプセル |
| WO2017018086A1 (ja) | 2015-07-29 | 2017-02-02 | 日本写真印刷株式会社 | マイクロニードルシート |
| IL242380A0 (en) | 2015-10-29 | 2016-02-01 | Yeda Res & Dev | A method of inducing cardiomyocytes proliferation and treating heart diseases |
| CA3003738C (en) | 2015-11-01 | 2021-01-12 | Massachusetts Institute Of Technology | Materials with improved properties |
| ES2978718T3 (es) * | 2015-11-01 | 2024-09-18 | Massachusetts Inst Technology | Alginatos modificados para materiales antifibróticos y aplicaciones |
| KR20180118659A (ko) | 2016-02-01 | 2018-10-31 | 바이오버라티브 테라퓨틱스 인크. | 최적화된 viii 인자 유전자 |
| JP7114485B2 (ja) | 2016-05-18 | 2022-08-08 | モデルナティエックス インコーポレイテッド | ファブリー病の治療のためのα－ガラクトシダーゼＡをコードするポリヌクレオチド |
| KR20230156818A (ko) | 2016-10-03 | 2023-11-14 | 시질론 테라퓨틱스, 인크. | 화합물, 장치, 및 이의 용도 |
| WO2018206168A1 (en) | 2017-05-11 | 2018-11-15 | Zentrum Für Forschungsförderung In Der Pädiatrie Gmbh | Concept for the treatment of monogenetic disorders |
| KR20200057051A (ko) | 2017-09-27 | 2020-05-25 | 시질론 테라퓨틱스, 인크. | 활성 세포를 포함하는 방법, 조성물 및 이식 가능한 요소 |
| WO2019195056A1 (en) | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising stem cells |
-
2019
- 2019-03-01 WO PCT/US2019/020405 patent/WO2019169333A1/en not_active Ceased
- 2019-03-01 EP EP19711765.8A patent/EP3759101A1/en active Pending
- 2019-03-01 JP JP2020544672A patent/JP2021516271A/ja active Pending
- 2019-03-01 AU AU2019226587A patent/AU2019226587A1/en not_active Abandoned
- 2019-03-01 KR KR1020207028383A patent/KR20210004969A/ko not_active Ceased
- 2019-03-01 IL IL276753A patent/IL276753B2/en unknown
- 2019-03-01 CA CA3092121A patent/CA3092121A1/en active Pending
- 2019-03-01 CN CN201980016665.2A patent/CN112105612A/zh active Pending
- 2019-03-01 US US16/977,724 patent/US12605486B2/en active Active
- 2019-03-04 TW TW108107146A patent/TW201938592A/zh unknown
-
2024
- 2024-01-26 JP JP2024010323A patent/JP2024052741A/ja active Pending
- 2024-07-11 AU AU2024204785A patent/AU2024204785A1/en active Pending